Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neuroectodermal Tumors, Primitive × fosbretabulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 3 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoid Tumor 1

Interventions

dactolisib 2 Everolimus 2 spartalizumab 1 pasireotide 1 fosbretabulin 1 cixutumumab 1 TH 302 1 PM 00104 1 ONC206 1 Fentanyl 1 CLR1404 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02132468 2017-12-05

GI-NETorPNET

Mateon Therapeutics

Phase 2 Completed

18 enrolled 10 charts

Carcinoid Tumor, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡